After 48 h of CCl 4 treatment, that is, on the sixth day, the animals were killed under light ether anesthesia. Blood was withdrawn from the carotid artery, allowed to coagulate at 37 o C for 30 min, serum separated by centrifugation at 2500
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Leucas aspera Leucas aspera Leucas aspera Leucas aspera on hepatotoxicity in rats on hepatotoxicity in rats on hepatotoxicity in rats on hepatotoxicity in rats on hepatotoxicity in rats rpm and analysed for serum glutamate oxaloacetate (SGOT) and serum glutamate pyruvate transaminase (SGPT). [7] The livers of the rats were promptly excised, serially sectioned, fixed in 10% formalin and 5 micron section were stained with haematoxylin and eosin for histopathological study. The results were statistically analysed using one-way analysis of variance (ANOVA) followed by Dunnett's test for individual comparisons. P < 0.01 were considered significant.
In experimental hepatopathy, the toxin (CCl 4 ) is biotransformed by cytochrome P450 to produce the trichloromethyl free radical. This in turn elicits lipid peroxidation of membrane lipids in the presence of oxygen generated by metabolic leakage from mitochondria. All these events culminate in loss of integrity of cell membranes and damage of hepatic tissue. [8] Assessment of liver function can be made by estimating the activities of serum GPT and GOT, which are enzymes originally present in higher concentration in cytoplasm. When there is hepatopathy, these enzymes leak into the blood stream in conformity with the extent of liver damage. The elevated levels of these marker enzymes in CCl 4 -treated rats in the present study corresponded to the extensive liver damage induced by the toxin. Pretreatment with the test drug LA (in both doses) as well as the standard drug silymarin significantly (P<0.01) reduced the elevation in liver enzymes, thereby showing that LA has hepatoprotective action (Table 1) Comparative histopathological study of the liver from different groups of rats corroborated the hepatoprotective efficacy of LA (Figure 1 ). Various pathological changes like steatosis, centrilobular necrosis, and vacuolisation seen in Group II rats were prevented to a moderate extent in Groups Values are mean ± SEM; n=6 in each group; df=3,20; *P <0.01 as compared to group I, **P <0.01 as compared to group II. CCl 4 was administered s.c. and the other substances were given orally.
III and IV. Because hepatotoxic effect of CCl 4 is due to oxidative damage by free radical generation, antioxidant property is claimed to be one of the mechanisms of hepatoprotective drugs. Further flavonoids have been suggested to act as antioxidants by free radical scavenging. Thus the hepatoprotective activity of LA may be attributed to the presence of flavonoids, though it is to be confirmed. Liver tissue of rats treated with silymarin: Practically complete recovery. Normal hepatocyte morphology.
